Zenas BioPharma, Inc. disclosed the approval of its Amended and Restated Short-Term Incentive Plan, effective January 1, 2026. This plan establishes a discretionary annual cash bonus program for eligible employees, linking potential payouts to company performance and individual achievement.
Key takeaways
The Board of Directors approved the Amended and Restated Short-Term Incentive Plan on February 10, 2026.
The plan is effective as of January 1, 2026.
It is an annual discretionary cash bonus plan for regular full- and part-time employees of the Company and its subsidiaries.
Bonus eligibility and amounts are determined based on Company performance and individual achievement of goals.
A participant must remain employed through the payment date, which is no later than March 15 following the applicable calendar year.
Awards are subject to the Company's Policy for Recoupment of Incentive Compensation and any other clawback policy.